DISEASE INCIDENCE AND PREVALENCE: EUROPE, JAPAN, RUSSIAN FEDERATION AND AUSTRALIA

299 Pages | 154 Exhibits | 1998 Analysis

OVERVIEW:
Geographic expansion represents one of today's most important growth opportunities for medical device manufacturers. Which markets are most appropriate for your company? Only with reliable patient population data can you make informed strategic planning decisions for: gauging international market opportunities; making sales and revenue projections; and distribution and sales territory decisions.

This reference resource compiled by Medtech Insight profiles 20 international markets, ranging from economies in transition to developed-market economies. Each country profile includes socio-economic indicators and health statistics, as well as the latest available incidence, prevalence, and discharge statistics for major diseases.

Disease categories include: cancer; cardiac and cardiovascular diseases; respiratory diseases; neurologic and psychiatric diseases and disorders; metabolic diseases; reproductive and genitourinary disorders; blood disorders; ophthalmologic diseases; musculoskeletal diseases; and human immunodeficiency virus/acquired immunodeficiency syndrome.

TABLE OF CONTENTS:
INTRODUCTION

1. OVERVIEW OF DISEASES

1.1 Cancer
	1.1.1 Lung Cancer
		1.1.1.1 Tobacco Smoking and Lung Cancer
	1.1.2 Colorectal Cancer
	1.1.3 Breast Cancer
	1.1.4 Prostate Cancer
	1.1.5 Pancreatic Cancer
	1.1.6 Uterine/Cervical Cancer
	1.1.7 Ovarian Cancer
	1.1.8 Leukemia
	1.1.9 Lymphoma
	1.1.10 Skin Cancer
	1.1.11 Bladder Cancer
	1.1.12 Oral Cancer
	1.1.13 Brain Tumors
1.2 Cardiac and Cardiovascular Diseases
	1.2.1 Cardiovascular Diseases
		1.2.1.1 Hypertension
		1.2.1.2 Hypercholesterolemia
		1.2.1.3 Ischemic Heart Disease
			1.2.1.3.1 Angina Pectoris
			1.2.1.3.2 Myocardial Infarction
		1.2.1.4 Congestive Heart Disease
		1.2.1.5 Atherosclerosis
			1.2.1.5.1 Coronary Atherosclerosis
			1.2.1.5.2 Peripheral Vascular Disease
	1.2.2 Pacing Disturbances
		1.2.2.1 Arrhythmias
		1.2.2.2 Tachycardias
			1.2.2.2.1 Ventricular Tachyarrhythmias
			1.2.2.2.2 Supraventricular Tachyarrhythmias
		1.2.2.3 Sudden Cardiac Death
	1.2.3 Valvular Heart Disease
		1.2.3.1 Valvular Stenosis
		1.2.3.2 Valvular Regurgitation
1.3 Respiratory Diseases
	1.3.1 Cystic Fibrosis
	1.3.2 Chronic Obstructive Pulmonary Disease
		1.3.2.1 Emphysema
		1.3.2.2 Chronic Bronchitis
	1.3.3 Asthma
	1.3.4 Restrictive Pulmonary Diseases
	1.3.5 Pulmonary Embolism
	1.3.6 Pleural Diseases
		1.3.6.1 Pneumothorax
		1.3.6.2 Pleural Effusion
		1.3.6.3 Empyema
	1.3.7 Infectious Diseases
		1.3.7.1 Pneumonia
		1.3.7.2 Tuberculosis
	1.3.8 Adult Respiratory Distress Syndrome
	1.3.9 Apnea
		1.3.9.1 Sleep Apnea
		1.3.9.2 Sudden Infant Death Syndrome
	1.3.10 Respiratory Failure
1.4 Neurologic and Psychiatric Diseases and Disorders
	1.4.1 Psychiatric Disorders
		1.4.1.1 Schizophrenia
		1.4.1.2 Mood-Affective Disorders
	1.4.2 Neurologic Diseases and Disorders
		1.4.2.1 Alzheimer's Disease
		1.4.2.2 Parkinson's Disease and Parkinsonism
		1.4.2.3 Multiple Sclerosis
		1.4.2.4 Epilepsy
		1.4.2.5 Cerebrovascular Disease
			1.4.2.5.1 Stroke
			1.4.2.5.2 Arteriovenous Malformations
			1.4.2.5.3 Cerebral Aneurysms
		1.4.2.6 Hydrocephalus
		1.4.2.7 Amyotrophic Lateral Sclerosis
		1.4.2.8 Myasthenia Gravis
		1.4.2.9 Huntington Disease
1.5 Metabolic Diseases
	1.5.1 Diabetes Mellitus
	1.5.2 Chronic Renal Failure
	1.5.3 End-Stage Renal Disease
	1.5.4 Urolithiasis
	1.5.5 Cholelithiasis
1.6 Reproductive and Genitourinary Disorders
	1.6.1 Disorders of the Female Reproductive Tract
		1.6.1.1 Endometriosis
		1.6.1.2 Female Infertility
			1.6.1.2.1 Ovulatory/Hormonal Disturbances
			1.6.1.2.2 Peritoneal Factors
			1.6.1.2.3 Cervical Factors
			1.6.1.2.4 Uterine Factors
	1.6.2 Disorders of the Male Reproductive Tract
		1.6.2.1 Impotence
		1.6.2.2 Benign Prostatic Hyperplasia
		1.6.2.3 Male Infertility
	1.6.3 Urinary Incontinence
1.7 Blood Disorders
	1.7.1 Hemophilia
	1.7.2 Anemias
		1.7.2.1 Iron Deficiency Anemia
		1.7.2.2 Thalassemias
		1.7.2.3 Sickle Cell Anemia
1.8 Ophthalmologic Diseases
	1.8.1 Cataracts
	1.8.2 Glaucoma
1.9 Musculoskeletal Diseases
	1.9.1 Osteoporosis
	1.9.2 Arthritis
		1.9.2.1 Osteoarthritis
		1.9.2.2 Rheumatoid Arthritis
	1.9.3 Carpal Tunnel Syndrome
	1.9.4 Duchenne's Muscular Dystrophy
1.10 Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
	1.10.1 Disease Progression

Exhibit 1-1: Acquired Immunodeficiency Syndrome Indicator Diseases

2. COUNTRY PROFILES

2.1 Australia
	2.1.1 Socio-Economic Indicators
	2.1.2 Health Statistics
2.2 Austria
	2.2.1 Socio-Economic Indicators
	2.2.2 Health Statistics
2.3 Belgium
	2.3.1 Socio-Economic Indicators
	2.3.2 Health Statistics
2.4 Czech Republic
	2.4.1 Socio-Economic Indicators
	2.4.2 Health Statistics
2.5 Denmark
	2.5.1 Socio-Economic Indicators
	2.5.2 Health Statistics
2.6 Finland
	2.6.1 Socio-Economic Indicators
	2.6.2 Health Statistics
2.7 France
	2.7.1 Socio-Economic Indicators
	2.7.2 Health Statistics
2.8 Germany
	2.8.1 Socio-Economic Indicators
	2.8.2 Health Statistics
2.9 Hungary
	2.9.1 Socio-Economic Indicators
	2.9.2 Health Statistics
2.10 Ireland
	2.10.1 Socio-Economic Indicators
	2.10.2 Health Statistics
2.11 Italy
	2.11.1 Socio-Economic Indicators
	2.11.2 Health Statistics
2.12 Japan
	2.12.1 Socio-Economic Indicators
	2.12.2 Health Statistics
2.13 The Netherlands
	2.13.1 Socio-Economic Indicators
	2.13.2 Health Statistics
2.14 Norway
	2.14.1 Socio-Economic Indicators
	2.14.2 Health Statistics
2.15 Poland
	2.15.1 Socio-Economic Indicators
	2.15.2 Health Statistics
2.16 Russian Federation
	2.16.1 Socio-Economic Indicators
	2.16.2 Health Statistics
2.17 Spain
	2.17.1 Socio-Economic Indicators
	2.17.2 Health Statistics
2.18 Sweden
	2.18.1 Socio-Economic Indicators
	2.18.2 Health Statistics
2.19 Switzerland
	2.19.1 Socio-Economic Indicators
	2.19.2 Health Statistics
2.20 United Kingdom
	2.20.1 Socio-Economic Indicators
	2.20.2 Health Statistics

Exhibit 2-1: Australia, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-2: Australia, Respiratory Disease Statistics
Exhibit 2-3: Australia, Metabolic Disease Statistics
Exhibit 2-4: Australia, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-5: Austria, Cancer Statistics
Exhibit 2-6: Austria, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-7: Austria, Respiratory Disease Statistics
Exhibit 2-8: Austria, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-9: Austria, Metabolic Disease Statistics
Exhibit 2-10: Austria, Ophthalmologic Disease Statistics
Exhibit 2-11: Austria, Musculoskeletal Disease Statistics
Exhibit 2-12: Austria, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-13: Belgium, Cancer Statistics
Exhibit 2-14: Belgium, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-15: Belgium, Respiratory Disease Statistics
Exhibit 2-16: Belgium, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-17: Belgium, Metabolic Disease Statistics
Exhibit 2-18: Belgium, Musculoskeletal Disease Statistics
Exhibit 2-19: Belgium, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-20: Czech Republic, Cancer Statistics
Exhibit 2-21: Czech Republic, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-22: Czech Republic, Respiratory Disease Statistics
Exhibit 2-23: Czech Republic, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-24: Czech Republic, Metabolic Disease Statistics
Exhibit 2-25: Czech Republic, Ophthalmologic Disease Statistics
Exhibit 2-26: Czech Republic, Musculoskeletal Disease Statistics
Exhibit 2-27: Czech Republic, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-28: Denmark, Cancer Statistics
Exhibit 2-29: Denmark, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-30: Denmark, Respiratory Disease Statistics
Exhibit 2-31: Denmark, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-32: Denmark, Metabolic Disease Statistics
Exhibit 2-33: Denmark, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-34: Denmark, Ophthalmologic Disease Statistics
Exhibit 2-35: Denmark, Musculoskeletal Disease Statistics
Exhibit 2-36: Denmark, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-37: Finland, Cancer Statistics
Exhibit 2-38: Finland, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-39: Finland, Respiratory Disease Statistics
Exhibit 2-40: Finland, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-41: Finland, Metabolic Disease Statistics
Exhibit 2-42: Finland, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-43: Finland, Ophthalmologic Disease Statistics
Exhibit 2-44: Finland, Musculoskeletal Disease Statistics
Exhibit 2-45: Finland, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-46: France, Cancer Statistics
Exhibit 2-47: France, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-48: France, Respiratory Disease Statistics
Exhibit 2-49: France, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-50: France, Metabolic Disease Statistics
Exhibit 2-51: France, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-52: France, Blood Disorder Statistics
Exhibit 2-53: France, Ophthalmologic Disease Statistics
Exhibit 2-54: France, Musculoskeletal Disease Statistics
Exhibit 2-55: France, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-56: Germany, Cancer Statistics
Exhibit 2-57: Germany, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-58: Germany, Respiratory Disease Statistics
Exhibit 2-59: Germany, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-60: Germany, Metabolic Disease Statistics
Exhibit 2-61: Germany, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-62: Germany, Blood Disorder Statistics
Exhibit 2-63: Germany, Ophthalmologic Disease Statistics
Exhibit 2-64: Germany, Musculoskeletal Disease Statistics
Exhibit 2-65: Germany, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-66: Hungary, Cancer Statistics
Exhibit 2-67: Hungary, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-68: Hungary, Respiratory Disease Statistics
Exhibit 2-69: Hungary, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-70: Hungary, Metabolic Disease Statistics
Exhibit 2-71: Hungary, Ophthalmologic Disease Statistics
Exhibit 2-72: Hungary, Musculoskeletal Disease Statistics
Exhibit 2-73: Hungary, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-74: Ireland, Cancer Statistics
Exhibit 2-75: Ireland, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-76: Ireland, Respiratory Disease Statistics
Exhibit 2-77: Ireland, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-78: Ireland, Metabolic Disease Statistics
Exhibit 2-79: Ireland, Ophthalmologic Disease Statistics
Exhibit 2-80: Ireland, Musculoskeletal Disease Statistics
Exhibit 2-81: Ireland, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-82: Italy, Cancer Statistics
Exhibit 2-83: Italy, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-84: Italy, Respiratory Disease Statistics
Exhibit 2-85: Italy, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-86: Italy, Metabolic Disease Statistics
Exhibit 2-87: Italy, Musculoskeletal Disease Statistics
Exhibit 2-88: Italy, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-89: Japan, Cancer Statistics
Exhibit 2-90: Japan, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-91: Japan, Respiratory Disease Statistics
Exhibit 2-92: Japan, Metabolic Disease Statistics
Exhibit 2-93: Japan, Musculoskeletal Disease Statistics
Exhibit 2-94: Japan, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-95: The Netherlands, Cancer Statistics
Exhibit 2-96: The Netherlands, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-97: The Netherlands, Respiratory Disease Statistics
Exhibit 2-98: The Netherlands, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-99: The Netherlands, Metabolic Disease Statistics
Exhibit 2-100: The Netherlands, Musculoskeletal Disease Statistics
Exhibit 2-101: The Netherlands, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-102: Norway, Cancer Statistics
Exhibit 2-103: Norway, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-104: Norway, Respiratory Disease Statistics
Exhibit 2-105: Norway, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-106: Norway, Metabolic Disease Statistics
Exhibit 2-107: Norway, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-108: Norway, Ophthalmologic Disease Statistics
Exhibit 2-109: Norway, Musculoskeletal Disease Statistics
Exhibit 2-110: Norway, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-111: Poland, Cancer Statistics
Exhibit 2-112: Poland, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-113: Poland, Respiratory Disease Statistics
Exhibit 2-114: Poland, Metabolic Disease Statistics
Exhibit 2-115: Poland, Musculoskeletal Disease Statistics
Exhibit 2-116: Poland, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-117: Russian Federation, Cancer Statistics
Exhibit 2-118: Russian Federation, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-119: Russian Federation, Respiratory Disease Statistics
Exhibit 2-120: Russian Federation, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-121: Russian Federation, Metabolic Disease Statistics
Exhibit 2-122: Russian Federation, Musculoskeletal Disease Statistics
Exhibit 2-123: Russian Federation, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-124: Spain, Cancer Statistics
Exhibit 2-125: Spain, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-126: Spain, Respiratory Disease Statistics
Exhibit 2-127: Spain, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-128: Spain, Metabolic Disease Statistics
Exhibit 2-129: Spain, Ophthalmologic Disease Statistics
Exhibit 2-130: Spain, Musculoskeletal Disease Statistics
Exhibit 2-131: Sweden, Cancer Statistics
Exhibit 2-132: Sweden, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-133: Sweden, Respiratory Disease Statistics
Exhibit 2-134: Sweden, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-135: Sweden, Metabolic Disease Statistics
Exhibit 2-136: Sweden, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-137: Sweden, Ophthalmologic Disease Statistics
Exhibit 2-138: Sweden, Musculoskeletal Disease Statistics
Exhibit 2-139: Sweden, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-140: Switzerland, Cancer Statistics
Exhibit 2-141: Switzerland, Respiratory Disease Statistics
Exhibit 2-142: Switzerland, Metabolic Disease Statistics
Exhibit 2-143: Switzerland, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics
Exhibit 2-144: United Kingdom, Cancer Statistics
Exhibit 2-145: United Kingdom, Cardiac and Cardiovascular Disease Statistics
Exhibit 2-146: United Kingdom, Respiratory Disease Statistics
Exhibit 2-147: United Kingdom, Neurologic and Psychiatric Disease and Disorder Statistics
Exhibit 2-148: United Kingdom, Metabolic Disease Statistics
Exhibit 2-149: United Kingdom, Reproductive and Genitourinary Disorder Statistics
Exhibit 2-150: United Kingdom, Blood Disorder Statistics
Exhibit 2-151: United Kingdom, Ophthalmologic Disease Statistics
Exhibit 2-152: United Kingdom, Musculoskeletal Disease Statistics
Exhibit 2-153: United Kingdom, Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome Statistics



COMPANIES COVERED:

Contact Us

Need help finding medtech research? Let us help you!